Dong Shin
Professor, Hematology and Medical Oncology · Emory University School of Medicine
Credentials: · · · · ·
History
- 1983–1985
Medical Oncology
Research
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
New England Journal of Medicine · 2006 · 3,932 citations
Nanoparticle therapeutics: an emerging treatment modality for cancer
Review · Nature Reviews Drug Discovery · 2008 · Last of 3 authors · 2,938 citations
Therapeutic nanoparticles for drug delivery in cancer
Review · Clinical Cancer Research · 2008 · Last of 5 authors · 1,745 citations
- FK
106 papers
105 papers
- WH
84 papers
- JB
43 papers
- BG
39 papers
36 papers · 3 as a fellow
33 papers · 1 as a fellow
33 papers
Grants
- 2023–2028
National Cancer Institute · R01
Contact PI · $2.6M · Emory University
- 2013–2020
Translational Physician-Scientist Training Program in Oncology
National Cancer Institute · T32
Contact PI · $1.2M · Emory University
- 2016–2019
Therapeutic siRNA Delivery Using DNA Nanoparticles (DNPs) for Cancer
National Institute of Biomedical Imaging and Bioengineering · R21
Contact PI · $429K · Emory University
- 2010–2016
Toxicity and Efficacy of Gold Nanoparticle Photothermal Therapy in Cancer
National Cancer Institute · U01
Contact PI · $2.1M · Emory University
Clinical trials
- 2025–2028
Principal investigator · Recruiting · Phase 1
Emory University
- 2018–2021
EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation
Principal investigator · Completed · Phase 2
Enzychem Lifesciences Corporation
- 2010–2018
Principal investigator · Completed · Phase 1
Emory University
- 2007–2016
Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2
Principal investigator · Completed · Phase 1
Emory University